DEFA14A: Aprea Therapeutics Sets Date for 2025 Annual Meeting, Outlines Voting Proposals

Aprea Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 5, 2025, with key proposals including the election of directors and ratification of the company's accounting firm.

Summary

• Aprea Therapeutics will hold its Annual Meeting of Stockholders virtually on June 5, 2025.
• Stockholders are being asked to vote on several key proposals.
• These proposals include the election of three Class III directors: Jean-Pierre Bizzari, M.D., Oren Gilad, Ph.D., and John B. Henneman III.
• Another proposal is to ratify the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year 2025.
• Additionally, stockholders will vote on the compensation of named executive officers and the frequency of future votes on executive compensation.
• The board recommends voting 'For' all listed proposals.
• The deadline to vote is June 4, 2025, at 11:59 PM ET.

Sentiment

Score: 7

Explanation: The document is a routine proxy statement, indicating standard corporate governance procedures. The sentiment is neutral to slightly positive as it reflects the company's engagement with its shareholders.

Positives

• The company is holding its annual meeting, allowing shareholders to participate in key decisions.
• Shareholders have the opportunity to vote on important matters such as the election of directors and the ratification of the accounting firm.
• The board's recommendations provide guidance to shareholders on how to vote.

Future Outlook

The document outlines the agenda for the upcoming annual meeting, focusing on corporate governance and executive compensation.

Industry Context

This announcement is a standard part of corporate governance, ensuring shareholders have a voice in the company's direction.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• The outcome of the votes will impact the composition of the board and the company's governance practices.

Next Steps

• Stockholders need to review the proxy materials and vote on the proposals by the deadline.
• The company will hold the Annual Meeting on June 5, 2025.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Executive Compensation, EisnerAmper, Voting, Aprea Therapeutics